NCT05589727

Brief Summary

Multicentric observational prospective cohort study in 12 (twelve) hospitals representing all Brazilian regions. The main objective of this project is to evaluate the incidence of Ventilator-Associated Pneumonia (VAP) when using the current ANVISA criteria for VAP versus VAE criteria defined by the National Healthcare Safety Network (NHSN). The diagnostic accuracy of the two criteria for identifying VAP will also be compared, characterizing other events associated with mechanical ventilation that are not VAP, when applicable. The study also aims to adjudicate ventilator-associated pneumonias reported to ANVISA using current epidemiological diagnostic criteria.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
987

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

12 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 21, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

October 21, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 21, 2024

Completed
Last Updated

November 20, 2024

Status Verified

November 1, 2024

Enrollment Period

1.2 years

First QC Date

October 13, 2022

Last Update Submit

November 18, 2024

Conditions

Keywords

pneumoniasurveillancehealthcare associated infectionsVentilator-Associated PneumoniaHealthcare-Associated Pneumonia

Outcome Measures

Primary Outcomes (1)

  • Incidence of Ventilator-Associated Pneumonia (VAP) using two different surveillance criteria.

    To evaluate the incidence of Ventilator-Associated Pneumonia (VAP) when using the current ANVISA criteria for VAP versus the criteria for events Ventilator-Associated Events (VAE) defined by the NHSN.

    through study completion, an average of 6 months

Secondary Outcomes (2)

  • Accuracy of the two criteria for identifying VAP

    through study completion, an average of 6 months

  • Adjudication of VAP

    through study completion, an average of 6 months

Study Arms (2)

Patients with VAP - ANVISA criteria

Patients notified with Ventilator-Associated Pneumonia (VAP) when using the current ANVISA criteria.

Patients with VAP - NHSN criteria

Patients notified with Ventilator-Associated Pneumonia (VAP) when using the Ventilator-Associated Events (VAE) criteria defined by the NHSN.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients aged 18 years or older who are hospitalized in intensive care units (ICUs) using mechanical ventilation.

You may qualify if:

  • Patients aged 18 years or older
  • Pacients hospitalized in intensive care units (ICUs) using mechanical ventilation

You may not qualify if:

  • Patients withdrawn from mechanical ventilation (MV) on the first day (D1) or second day (D2), with D1 being the day of initiation of MV;
  • Patients with hospital discharge (discharge, death or transfer) on D1 or D2 of mechanical ventilation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

Hospital São Vicente de Paula

Barbalha, Ceará, Brazil

Location

Hospital OTOclínica

Fortaleza, Ceará, Brazil

Location

Hospital Universitário de Brasília

Brasília, Federal District, Brazil

Location

Hospital Geral de Goiânia Alberto Rassi

Goiânia, Goiás, Brazil

Location

Hospital Presidente Vargas

São Luís, Maranhão, Brazil

Location

Hospital Municipal de Maringá

Maringá, Paraná, Brazil

Location

Hospital Jean Bittar

Belém, Pará, Brazil

Location

Hospital do Tricentenário

Olinda, Pernambuco, Brazil

Location

Instituto Estadual do Cérebro Paulo Niemeyer

Rio de Janeiro, Rio de Janeiro, Brazil

Location

Hospital Geral de Caxias do Sul

Caxias do Sul, Rio Do Grande Do Sul, Brazil

Location

Hospital Ernesto Dornelles

Porto Alegre, Rio Grande do Sul, Brazil

Location

A. C. Camargo Cancer Center

São Paulo, São Paulo, Brazil

Location

Related Publications (11)

  • Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008 Jun;36(5):309-32. doi: 10.1016/j.ajic.2008.03.002. No abstract available.

    PMID: 18538699BACKGROUND
  • Klompas M. Ventilator-Associated Events: What They Are and What They Are Not. Respir Care. 2019 Aug;64(8):953-961. doi: 10.4187/respcare.07059.

    PMID: 31346070BACKGROUND
  • Klompas M. The paradox of ventilator-associated pneumonia prevention measures. Crit Care. 2009;13(5):315. doi: 10.1186/cc8036. Epub 2009 Oct 15.

    PMID: 19849825BACKGROUND
  • Fan Y, Gao F, Wu Y, Zhang J, Zhu M, Xiong L. Does ventilator-associated event surveillance detect ventilator-associated pneumonia in intensive care units? A systematic review and meta-analysis. Crit Care. 2016 Oct 24;20(1):338. doi: 10.1186/s13054-016-1506-z.

    PMID: 27772529BACKGROUND
  • Raoof S, Baumann MH; Critical Care Societies Collaborative, consisting of the leadership of the American Association of Critical-Care Nurses, the American College of Chest Physicians, the American Thoracic Society, and the Society of Critical Care Medicine. Ventilator-associated events: the new definition. Am J Crit Care. 2014 Jan;23(1):7-9. doi: 10.4037/ajcc2014469. No abstract available.

    PMID: 24382609BACKGROUND
  • Stevens JP, Silva G, Gillis J, Novack V, Talmor D, Klompas M, Howell MD. Automated surveillance for ventilator-associated events. Chest. 2014 Dec;146(6):1612-1618. doi: 10.1378/chest.13-2255.

    PMID: 25451350BACKGROUND
  • Hebert C, Flaherty J, Smyer J, Ding J, Mangino JE. Development and validation of an automated ventilator-associated event electronic surveillance system: A report of a successful implementation. Am J Infect Control. 2018 Mar;46(3):316-321. doi: 10.1016/j.ajic.2017.09.006. Epub 2017 Nov 10.

    PMID: 29132696BACKGROUND
  • Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005 Mar;85(3):257-68.

    PMID: 15733050BACKGROUND
  • Donner A, Eliasziw M. A goodness-of-fit approach to inference procedures for the kappa statistic: confidence interval construction, significance-testing and sample size estimation. Stat Med. 1992 Aug;11(11):1511-9. doi: 10.1002/sim.4780111109.

    PMID: 1410963BACKGROUND
  • Nascimento GM, Rodrigues DLG, Piastrelli FT, Cheno MY, Braz KCC, Alves LBO, Tomazini BM, Veiga VC, Arns B, Besen BAMP, Junior APN, Avezum A, da Silva RKL, de Azevedo CMPES, Silva MLSO, Kist GR, Salgado FB, de Moura MTF, Boschi E, Kurtz PMP, Miraglia ERVDS, de Lima TA, Pereira RR, Arraes JA, Alves de Oliveira Junior H. Ventilator-associated events criteria in the assessment of Ventilator-Associated Pneumonia (IMPACTO MR-PAV): A prospective cohort. Braz J Infect Dis. 2025 Jul-Aug;29(4):104543. doi: 10.1016/j.bjid.2025.104543. Epub 2025 May 22.

  • Nascimento GM, Gomes Rodrigues DL, Mangas Catarino DG, Piastrelli FT, Cheno MY, Braz KCC, Oliveira Alves LB, Avezum A, Veiga VC, Zavascki AP, Tomazini B, Besen B, Pereira AJ, Marques de Pinho APN, De Oliveira Junior HA. Application of ventilator-associated events (VAE) in ventilator-associated pneumonia (VAP) notified in Brazil (IMPACTO MR-PAV): a protocol for a cohort study. BMJ Open. 2023 Dec 9;13(12):e076047. doi: 10.1136/bmjopen-2023-076047.

MeSH Terms

Conditions

Pneumonia, Ventilator-AssociatedHealthcare-Associated PneumoniaCross InfectionPneumonia

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract InfectionsLung DiseasesRespiratory Tract DiseasesIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Giovanna M Nascimento, MD

    Hospital Alemão Oswaldo Cruz

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 13, 2022

First Posted

October 21, 2022

Study Start

October 21, 2022

Primary Completion

December 21, 2023

Study Completion

January 21, 2024

Last Updated

November 20, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations